IV DHE

Related by string. * IVS . IVs . IVD . iv . Iver . Iv . iving . iver : Street Fighter IV . Sid Meier Civilization IV . Paragraph IV certification . Elder Scrolls IV Oblivion . Paragraph IV Certification . Yusuf Bey IV . Saw IV . AJ Foyt IV / dhe . Dheer : Ashwini Dheer . Nikitin Dheer . Pankaj Dheer . dihydroergotamine mesylate DHE . dihydroergotamine DHE . dihydroergotamine DHE drug . Ashwani Dheer * *

Related by context. Frequent words. (Click for all words.) 58 plus methotrexate 58 serum concentrations 58 placebo p = 57 ziprasidone 57 tamsulosin 56 adefovir 56 esomeprazole 56 dose regimens 56 mcg kg 56 plasma concentrations 55 plus prednisone 55 peginterferon alfa 2a 55 epoetin alfa 55 tobramycin 55 mg BID 55 rHuPH# 55 unfractionated heparin 54 adalimumab 54 ketoconazole 54 peginterferon alfa 2b 54 Secondary endpoints included 54 budesonide 54 mitoxantrone 53 serum phosphorus 53 glimepiride 53 LMWH 53 lamotrigine 53 #mg dose [003] 53 dosing regimens 53 bosentan 53 dacarbazine 53 antithrombotic 52 intravenously administered 52 lacosamide 52 Tolerability 52 Adverse events 52 pharmacokinetic profile 52 fluticasone 52 pravastatin 52 non inferiority 52 etanercept 51 fluorouracil 51 FOLFIRI 51 decitabine 51 subcutaneous injections 51 pramipexole 51 linezolid 51 haloperidol 51 inactive placebo 51 abciximab 51 prespecified 51 azathioprine 51 P = .# 51 thromboembolic events 51 febuxostat 51 randomized #:# 51 noninferiority 51 formoterol 51 angiotensin receptor blocker 51 FOLFOX 50 interferon alfa 50 mg dose 50 Secondary endpoints include 50 tiotropium 50 placebo 50 amlodipine 50 sitagliptin 49 demonstrated statistically significant 49 lopinavir ritonavir 49 STELARA 49 pioglitazone 49 plus ribavirin 49 events AEs 49 NRTI 49 bronchodilator 49 venlafaxine 49 tacrolimus 49 tolerability 49 epoetin 49 Secondary endpoints 49 pharmacodynamic 48 pharmacodynamics 48 discontinuations due 48 sirolimus 48 fondaparinux 48 limiting toxicity 48 enoxaparin 48 metoprolol 48 antiplatelet 48 creatinine clearance 48 events SAEs 48 treatment emergent adverse 48 p = #.# [004] 48 tolerability profile 48 severe renal impairment 48 LIALDA 48 insulin glargine 48 5mg 48 abacavir 48 fludarabine 47 valsartan

Back to home page